T1	Participants 125 183	'high risk' pre- and postmenopausal breast cancer patients
T2	Participants 314 321	Sweden.
T3	Participants 625 677	pre- (n = 547) and postmenopausal (n = 679) patients
T4	Participants 693 748	with node positive disease or a tumour diameter > 30 mm
